Archive by author:
Howard FienbergReturn
Based in Washington, DC, Howard is the Insights Association's lobbyist for the marketing research and data analytics industry, focusing primarily on consumer privacy and data security, the Telephone Consumer Protection Act (TCPA), tort reform, and the funding and integrity of the decennial Census and the American Community Survey (ACS).
Howard has more than two decades of public policy experience. Before the Insights Association, he worked in Congress as senior legislative staffer for then-Representatives Christopher Cox (CA-48) and Cliff Stearns (FL-06). He also served more than four years with a science policy think tank, working to improve the understanding of scientific and social research and methodology among journalists and policymakers.
Howard is also co-director of The Census Project, a 900+ member coalition in support of a fair and accurate Census and ACS.
He has also served previously on the Board of Directors for the National Institute for Lobbying and Ethics and and the Association of Government Relations Professionals.
Howard has an MA International Relations from the University of Essex in England and a BA Honors Political Studies from Trent University in Canada, and has obtained the Certified Association Executive (CAE), Professional Lobbying Certificate (PLC) and the Public Policy Certificate (PPC).
When not running advocacy for the Insights Association, Howard enjoys hockey, NFL football, sci-fi and horror movies, playing with his dog, and spending time with family and friends.
New regulations in New Jersey restricting interactions between medical professionals and pharmaceutical manufacturers should not impede marketing research, thanks to the advocacy of the Insights Association, the leading nonprofit association representing the marketing research and analytics industry.
Read More
Companies who need to access the national number portability database include marketing research companies.
Read More
Seeking to clarify the regulatory distinction between the intent to market and sell to individuals and the dissimilar intent to understand market needs, the Insights Association and AAPOR have filed a petition with the FCC to secure "greater clarity" that will be "critical to restoring a measure of sanity to TCPA litigation."
Read More
A leading research association testified at a hearing in New Jersey on October 19, 2017 about proposed regulations on payments to medical professionals, urging an exemption for pharmaceutical marketing research incentive payments.
Read More
Are all people who need to access the national number portability database "telemarketers?"
Read More
The Federal Communications Commission (FCC) should require voice service providers and call blocking service providers to check a white list of legitimate dialers before blocking a telephone number, according to comments from a leading research association.
Read More
A new set of industry best practices for protecting consumer privacy in facial recognition technology, resulting from a multistakeholder process overseen by a federal government agency, will advance privacy safeguards while also carving out most research and analytics uses of the technology.
Read More
America’s two national associations representing the profession and industry of survey, opinion and marketing research have filed a “motion to intervene” in a court case against new telephone rules from the Federal Communications Commission (FCC).
Read More
New rules for telephone research from the Federal Communications Commission (FCC) have dramatically raised the liability risks for telephone survey, opinion and marketing research in the U.S., causing some research companies to go so far in response as to discard most of their dialing equipment. The FCC approved new rules for the Telephone Consumer Protection Act (TCPA) in a Declaratory Ruling and Order on June 18, and released them to the public on July 10 — when the rules immediately went int...
Read More
On August 1, 2013, the first reporting period under the Physician Payment Sunshine Act began. Part of the Patient Protection and Affordable Care Act (aka, “Obamacare”), it requires pharmaceutical and medical device manufacturers to publicly report many types of payments made to physicians, which will be public. The Sunshine Act was intended to bring transparency to these relationships, to minimize manufacturers’ influence on physicians’ prescribing behavior.
Read More